SLC6A3 and depressive symptom measurement: However, DAT methylation predicted relapse as a trend in AD patients with low BDI scores (t22=2.07, P=0.051), whereas not in patients with mild/moderate depression scores (U=3, P=1; but please note that the sample size was only five in this group).